Work

Phase III Randomized, Placebo(Pl)-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium (CaMg) to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (sNT), N08CB: an Alliance for Clinical Trials in Oncology Study1

Year: 2013

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdt201.32

Authors: Axel Grothey, Rui Qin, Shaker Dakhil, Louis Fehrenbacher, Philip Stella, Pamela Atherton, Drew Seisler, Rubin Qamar, Grant Lewis, Charles Loprinzi

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Cancer Center of Kansas, Kaiser Permanente, Kaiser Permanente Vallejo Medical Center, Michigan Cancer Research Consortium, Aurora Health Care

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2099253579

FWCI: 2.143

Cites:

Cited by: 14

Related to: 10